Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Sanofi - American Depositary Shares
(NQ:
SNY
)
48.36
+0.04 (+0.08%)
Streaming Delayed Price
Updated: 1:00 PM EST, Dec 24, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
807,260
Open
48.34
Bid (Size)
48.20 (300)
Ask (Size)
48.44 (300)
Prev. Close
48.32
Today's Range
48.16 - 48.49
52wk Range
44.62 - 60.12
Shares Outstanding
1,250,690,553
Dividend Yield
4.57%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Why Dynavax Stock Soared Today
↗
Today 15:55 EST
A healthcare titan wants to buy the biotech's vaccines.
Via
The Motley Fool
Sanofi’s $2.2 Billion Strategic Pivot: Deconstructing the Dynavax Acquisition and the Future of Specialty Medicine
Today 10:23 EST
As of today, December 24, 2025, the global pharmaceutical landscape is witnessing a profound consolidation of power within specialty medicine and immunology. Sanofi (NASDAQ: SNY; Euronext: SAN), the...
Via
PredictStreet
Topics
Artificial Intelligence
Economy
Intellectual Property
Performance
YTD
+0.4%
+0.4%
1 Month
-1.6%
-1.6%
3 Month
+3.2%
+3.2%
6 Month
-0.1%
-0.1%
1 Year
-0.1%
-0.1%
More News
Read More
Dynavax Technologies: Analyzing the 39% Surge and Sanofi Acquisition
Today 10:21 EST
Via
PredictStreet
Topics
Economy
Sanofi Acquires Dynavax in $2.2 Billion Christmas Eve Deal, Sending Shares Soaring
Today 10:12 EST
Via
MarketMinute
Topics
Intellectual Property
Why Did Dynavax Stock Surge 38% In Premarket Today?
↗
Today 5:56 EST
Via
Stocktwits
Fitch Sees Stable 2026 Outlook For Global Pharma — But Warns Trump Drug Pricing Push Poses Profit Risk
↗
December 23, 2025
Via
Stocktwits
Topics
Government
Dupixent® (dupilumab) Approved in Japan for Children Aged 6 to 11 Years with Bronchial Asthma
December 23, 2025
From
Regeneron Pharmaceuticals, Inc.
Via
GlobeNewswire
The Biotech Renaissance: Innovation and M&A Frenzy Spark a Historic Year-End Rally
December 22, 2025
Via
MarketMinute
Topics
ETFs
Economy
Intellectual Property
Trump Strikes New Drug-Price Deals With Roche, Novartis, Merck And Other Pharma Giants
↗
December 19, 2025
Via
Stocktwits
Topics
Government
World Trade
Is Alnylam Pharmaceuticals a Millionaire Maker?
↗
December 07, 2025
Via
The Motley Fool
Moderna, BioNTech Slammed After FDA Links Covid Shots To 10 Deaths
↗
December 01, 2025
Via
Investor's Business Daily
Topics
Death
Should You Buy This Biotech Stock That Just Gained 5% in 1 Day?
↗
November 30, 2025
Via
The Motley Fool
Sanofi Stock Drops After Confirming Raid, Tax Fraud Investigation
↗
November 26, 2025
Via
Investor's Business Daily
Topics
Fraud
Dupixent® (dupilumab) Approved as the First Targeted Medicine in the European Union (EU) in Over a Decade for Chronic Spontaneous Urticaria (CSU)
November 25, 2025
From
Regeneron Pharmaceuticals, Inc.
Via
GlobeNewswire
AI Revolutionizes Drug Shelf-Life: Optimized Stability Models Promise Safer, More Effective Medicines
November 14, 2025
Via
TokenRing AI
Topics
Artificial Intelligence
Economy
Product Recall
Biopharma Boom: M&A Frenzy, AI Revolution, and GLP-1 Gold Rush Drive Robust Growth in 2025
November 14, 2025
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Intellectual Property
Why Roche Holding Stock Popped Today
↗
November 10, 2025
Via
The Motley Fool
TG Therapeutics Crumbles After Roche Unveils Its 'Unprecedented' Test Results
↗
November 10, 2025
Via
Investor's Business Daily
Merck Takes On Amgen, Regeneron, Lowering Stubbornly High Cholesterol By 60%
↗
November 08, 2025
Via
Investor's Business Daily
AI Achieves Atomic Precision in Antibody Design: A New Era for Drug Discovery Dawns
November 05, 2025
Via
TokenRing AI
Topics
Artificial Intelligence
Intellectual Property
AI Unleashes a New Era in Cell and Gene Therapy: A Quarter Century Update Reveals Transformative Potential
November 04, 2025
Via
TokenRing AI
Topics
Artificial Intelligence
AI Unleashes a New Era: Biopharma’s Accelerated Revolution and the Rise of TechBio
November 01, 2025
Via
TokenRing AI
Topics
Animal Testing
Artificial Intelligence
Economy
Regeneron's Q3 Earnings Outperform Expectations With Dupixent Strength Balancing Eylea Weakness
↗
October 28, 2025
Via
Benzinga
UPDATE - Medidata Extends Collaboration with Sanofi for the Development of New Therapies with an Improved Patient Journey
October 27, 2025
From
Medidata Solutions, Inc.
Via
GlobeNewswire
Sanofi Soars as Dupixent Sales Near €5 Billion Amidst Intensifying Trump Drug Pricing Negotiations
October 24, 2025
Via
MarketMinute
Topics
Government
World Trade
Frequently Asked Questions
Is Sanofi - American Depositary Shares publicly traded?
Yes, Sanofi - American Depositary Shares is publicly traded.
What exchange does Sanofi - American Depositary Shares trade on?
Sanofi - American Depositary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Sanofi - American Depositary Shares?
The ticker symbol for Sanofi - American Depositary Shares is SNY on the Nasdaq Stock Market
What is the current price of Sanofi - American Depositary Shares?
The current price of Sanofi - American Depositary Shares is 48.36
When was Sanofi - American Depositary Shares last traded?
The last trade of Sanofi - American Depositary Shares was at 12/24/25 01:00 PM ET
What is the market capitalization of Sanofi - American Depositary Shares?
The market capitalization of Sanofi - American Depositary Shares is 60.48B
How many shares of Sanofi - American Depositary Shares are outstanding?
Sanofi - American Depositary Shares has 60B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
